{"transactions":[{"id":306911,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Chief Patient & Ext Af Off"}}],"security":"Common Stock","published_at":"2026-07-23T20:13:11.000Z","date":"2026-07-21","kind":"grant","planned":false,"acquired":true,"shares":8251,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock unit award that vests on 03/31/2030."}],"balance_after":66512,"source":{"system":"sec-edgar","filing":"0000875320-26-000251","document":"wk-form4_1784837586.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000251/wk-form4_1784837586.xml","form_type":"4"}},{"id":312726,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Chief Patient & Ext Af Off"}}],"security":"Common Stock","published_at":"2026-02-26T23:50:47.000Z","date":"2026-02-25","kind":"sale","planned":true,"acquired":false,"shares":1846,"price":486.35,"value":897802.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1, which was entered into on 11/18/2025."}],"balance_after":55570,"source":{"system":"sec-edgar","filing":"0000875320-26-000118","document":"wk-form4_1772149844.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000118/wk-form4_1772149844.xml","form_type":"4"}},{"id":312725,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Chief Patient & Ext Af Off"}}],"security":"Common Stock","published_at":"2026-02-26T23:50:47.000Z","date":"2026-02-24","kind":"tax_withholding","planned":true,"acquired":false,"shares":1518,"price":485.11,"value":736396.98,"ownership":{"direct":true},"balance_after":57416,"source":{"system":"sec-edgar","filing":"0000875320-26-000118","document":"wk-form4_1772149844.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000118/wk-form4_1772149844.xml","form_type":"4"}},{"id":312985,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Chief Patient & Ext Af Off"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-23T21:21:44.000Z","date":"2026-02-19","kind":"exercise","planned":true,"acquired":false,"shares":25026,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"Fully vested."}],"balance_after":0,"derivative":{"exercise_price":187.53,"expiration_date":"2029-02-05","underlying":"Common Stock","underlying_shares":25026},"source":{"system":"sec-edgar","filing":"0000875320-26-000102","document":"wk-form4_1771881700.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000102/wk-form4_1771881700.xml","form_type":"4"}},{"id":312984,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Chief Patient & Ext Af Off"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-23T21:21:44.000Z","date":"2026-02-19","kind":"exercise","planned":true,"acquired":false,"shares":23479,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"Fully vested."}],"balance_after":0,"derivative":{"exercise_price":155.57,"expiration_date":"2028-02-05","underlying":"Common Stock","underlying_shares":23479},"source":{"system":"sec-edgar","filing":"0000875320-26-000102","document":"wk-form4_1771881700.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000102/wk-form4_1771881700.xml","form_type":"4"}},{"id":312983,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Chief Patient & Ext Af Off"}}],"security":"Common Stock","published_at":"2026-02-23T21:21:44.000Z","date":"2026-02-19","kind":"sale","planned":true,"acquired":false,"shares":4237,"price":471.43,"value":1997448.91,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1, which was entered into on 11/18/2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"Open market sales reported on this line occurred at a weighted average price of $471.43 (range $471.10 to $472.03)."}],"balance_after":58934,"source":{"system":"sec-edgar","filing":"0000875320-26-000102","document":"wk-form4_1771881700.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000102/wk-form4_1771881700.xml","form_type":"4"}},{"id":312982,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Chief Patient & Ext Af Off"}}],"security":"Common Stock","published_at":"2026-02-23T21:21:44.000Z","date":"2026-02-19","kind":"sale","planned":true,"acquired":false,"shares":11712,"price":470.54,"value":5510964.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1, which was entered into on 11/18/2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Open market sales reported on this line occurred at a weighted average price of $470.54 (range $470.10 to $471.08)."}],"balance_after":63171,"source":{"system":"sec-edgar","filing":"0000875320-26-000102","document":"wk-form4_1771881700.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000102/wk-form4_1771881700.xml","form_type":"4"}},{"id":312981,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Chief Patient & Ext Af Off"}}],"security":"Common Stock","published_at":"2026-02-23T21:21:44.000Z","date":"2026-02-19","kind":"sale","planned":true,"acquired":false,"shares":7241,"price":469.61,"value":3400446.01,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1, which was entered into on 11/18/2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Open market sales reported on this line occurred at a weighted average price of $469.61 (range $469.10 to $470.05)."}],"balance_after":74883,"source":{"system":"sec-edgar","filing":"0000875320-26-000102","document":"wk-form4_1771881700.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000102/wk-form4_1771881700.xml","form_type":"4"}},{"id":312980,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Chief Patient & Ext Af Off"}}],"security":"Common Stock","published_at":"2026-02-23T21:21:44.000Z","date":"2026-02-19","kind":"sale","planned":true,"acquired":false,"shares":19662,"price":468.57,"value":9213023.34,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1, which was entered into on 11/18/2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Open market sales reported on this line occurred at a weighted average price of $468.57 (range $468.10 to $469.09)."}],"balance_after":82124,"source":{"system":"sec-edgar","filing":"0000875320-26-000102","document":"wk-form4_1771881700.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000102/wk-form4_1771881700.xml","form_type":"4"}},{"id":312979,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Chief Patient & Ext Af Off"}}],"security":"Common Stock","published_at":"2026-02-23T21:21:44.000Z","date":"2026-02-19","kind":"sale","planned":true,"acquired":false,"shares":10263,"price":467.75,"value":4800518.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1, which was entered into on 11/18/2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Open market sales reported on this line occurred at a weighted average price of $467.75 (range $467.09 to $468.05)."}],"balance_after":101786,"source":{"system":"sec-edgar","filing":"0000875320-26-000102","document":"wk-form4_1771881700.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000102/wk-form4_1771881700.xml","form_type":"4"}},{"id":312978,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Chief Patient & Ext Af Off"}}],"security":"Common Stock","published_at":"2026-02-23T21:21:44.000Z","date":"2026-02-19","kind":"sale","planned":true,"acquired":false,"shares":1848,"price":465.8,"value":860798.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1, which was entered into on 11/18/2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Open market sales reported on this line occurred at a weighted average price of $465.80 (range $465.54 to $466.49)."}],"balance_after":112049,"source":{"system":"sec-edgar","filing":"0000875320-26-000102","document":"wk-form4_1771881700.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000102/wk-form4_1771881700.xml","form_type":"4"}},{"id":312977,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Chief Patient & Ext Af Off"}}],"security":"Common Stock","published_at":"2026-02-23T21:21:44.000Z","date":"2026-02-19","kind":"sale","planned":true,"acquired":false,"shares":2730,"price":465.05,"value":1269586.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1, which was entered into on 11/18/2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $465.05 (range $464.48 to $465.46)."}],"balance_after":113897,"source":{"system":"sec-edgar","filing":"0000875320-26-000102","document":"wk-form4_1771881700.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000102/wk-form4_1771881700.xml","form_type":"4"}},{"id":312976,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Chief Patient & Ext Af Off"}}],"security":"Common Stock","published_at":"2026-02-23T21:21:44.000Z","date":"2026-02-19","kind":"sale","planned":true,"acquired":false,"shares":920,"price":463.91,"value":426797.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1, which was entered into on 11/18/2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Open market sales reported on this line occurred at a weighted average price of $463.91 (range $463.44 to $464.28)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":116627,"source":{"system":"sec-edgar","filing":"0000875320-26-000102","document":"wk-form4_1771881700.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000102/wk-form4_1771881700.xml","form_type":"4"}},{"id":312975,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Chief Patient & Ext Af Off"}}],"security":"Common Stock","published_at":"2026-02-23T21:21:44.000Z","date":"2026-02-19","kind":"exercise","planned":true,"acquired":true,"shares":25026,"price":187.53,"value":4693125.78,"ownership":{"direct":true},"balance_after":117547,"source":{"system":"sec-edgar","filing":"0000875320-26-000102","document":"wk-form4_1771881700.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000102/wk-form4_1771881700.xml","form_type":"4"}},{"id":312974,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Chief Patient & Ext Af Off"}}],"security":"Common Stock","published_at":"2026-02-23T21:21:44.000Z","date":"2026-02-19","kind":"exercise","planned":true,"acquired":true,"shares":23479,"price":155.57,"value":3652628.03,"ownership":{"direct":true},"balance_after":92521,"source":{"system":"sec-edgar","filing":"0000875320-26-000102","document":"wk-form4_1771881700.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000102/wk-form4_1771881700.xml","form_type":"4"}},{"id":313133,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Chief Patient & Ext Af Off"}}],"security":"Common Stock","published_at":"2026-02-19T21:24:59.000Z","date":"2026-02-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":2140,"price":483.75,"value":1035225.0,"ownership":{"direct":true},"balance_after":69042,"source":{"system":"sec-edgar","filing":"0000875320-26-000096","document":"wk-form4_1771536296.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000096/wk-form4_1771536296.xml","form_type":"4"}},{"id":313132,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Chief Patient & Ext Af Off"}}],"security":"Common Stock","published_at":"2026-02-19T21:24:59.000Z","date":"2026-02-17","kind":"grant","planned":false,"acquired":true,"shares":5789,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock unit award that vests in installments beginning on February 20, 2027."}],"balance_after":71182,"source":{"system":"sec-edgar","filing":"0000875320-26-000096","document":"wk-form4_1771536296.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000096/wk-form4_1771536296.xml","form_type":"4"}},{"id":313473,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Chief Patient & Ext Af Off"}}],"security":"Common Stock","published_at":"2026-02-18T21:39:54.000Z","date":"2026-02-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":3548,"price":487.76,"value":1730572.48,"ownership":{"direct":true},"balance_after":65393,"source":{"system":"sec-edgar","filing":"0000875320-26-000074","document":"wk-form4_1771450792.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000074/wk-form4_1771450792.xml","form_type":"4"}},{"id":313860,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Chief Patient & Ext Af Off"}}],"security":"Common Stock","published_at":"2026-02-12T22:06:16.000Z","date":"2026-02-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":2057,"price":468.41,"value":963519.37,"ownership":{"direct":true},"balance_after":68941,"source":{"system":"sec-edgar","filing":"0000875320-26-000050","document":"wk-form4_1770933974.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000050/wk-form4_1770933974.xml","form_type":"4"}},{"id":314827,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Chief Patient & Ext Af Off"}}],"security":"Common Stock","published_at":"2026-01-26T21:35:01.000Z","date":"2026-01-22","kind":"grant","planned":false,"acquired":true,"shares":3883,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents earned performance shares with respect to a performance stock unit award granted on 02/12/2025 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 01/22/2026 and the shares will vest in installments beginning on 02/24/2026."}],"balance_after":70998,"source":{"system":"sec-edgar","filing":"0000875320-26-000024","document":"wk-form4_1769463298.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000024/wk-form4_1769463298.xml","form_type":"4"}},{"id":314826,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Chief Patient & Ext Af Off"}}],"security":"Common Stock","published_at":"2026-01-26T21:35:01.000Z","date":"2026-01-22","kind":"grant","planned":false,"acquired":true,"shares":7866,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents earned performance shares with respect to a performance stock unit award granted on 02/01/2023 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 01/22/2026 and the shares will vest on 02/13/2026."}],"balance_after":67115,"source":{"system":"sec-edgar","filing":"0000875320-26-000024","document":"wk-form4_1769463298.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000024/wk-form4_1769463298.xml","form_type":"4"}},{"id":325020,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Chief Patient & Ext Af Off"}}],"security":"Common Stock","published_at":"2025-02-28T21:46:03.000Z","date":"2025-02-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":3703,"price":479.61,"value":1775995.83,"ownership":{"direct":true},"balance_after":68490,"source":{"system":"sec-edgar","filing":"0000875320-25-000133","document":"wk-form4_1740779155.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532025000133/wk-form4_1740779155.xml","form_type":"4"}},{"id":325176,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Chief Patient & Ext Af Off"}}],"security":"Common Stock","published_at":"2025-02-26T21:13:38.000Z","date":"2025-02-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":2470,"price":483.28,"value":1193701.6,"ownership":{"direct":true},"balance_after":72193,"source":{"system":"sec-edgar","filing":"0000875320-25-000113","document":"wk-form4_1740604411.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532025000113/wk-form4_1740604411.xml","form_type":"4"}},{"id":325781,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Chief Patient & Ext Af Off"}}],"security":"Common Stock","published_at":"2025-02-19T21:34:58.000Z","date":"2025-02-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":2139,"price":463.46,"value":991340.94,"ownership":{"direct":true},"balance_after":74663,"source":{"system":"sec-edgar","filing":"0000875320-25-000093","document":"wk-form4_1740000892.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532025000093/wk-form4_1740000892.xml","form_type":"4"}},{"id":326065,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Chief Patient & Ext Af Off"}}],"security":"Common Stock","published_at":"2025-02-14T21:14:37.000Z","date":"2025-02-12","kind":"grant","planned":false,"acquired":true,"shares":6211,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock unit award that vests in installments beginning on 02/24/2026."}],"balance_after":76802,"source":{"system":"sec-edgar","filing":"0000875320-25-000069","document":"wk-form4_1739567669.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532025000069/wk-form4_1739567669.xml","form_type":"4"}},{"id":326168,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Chief Patient & Ext Af Off"}}],"security":"Common Stock","published_at":"2025-02-12T21:48:05.000Z","date":"2025-02-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":2056,"price":467.98,"value":962166.88,"ownership":{"direct":true},"balance_after":70591,"source":{"system":"sec-edgar","filing":"0000875320-25-000046","document":"wk-form4_1739396879.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532025000046/wk-form4_1739396879.xml","form_type":"4"}},{"id":326549,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Chief Patient & Ext Af Off"}}],"security":"Common Stock","published_at":"2025-02-06T21:41:46.000Z","date":"2025-02-04","kind":"grant","planned":false,"acquired":true,"shares":7114,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents earned performance shares with respect to a performance stock unit award granted on 02/07/2024 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/04/2025 and the shares will vest in installments beginning on 02/17/2025."}],"balance_after":72647,"source":{"system":"sec-edgar","filing":"0000875320-25-000022","document":"wk-form4_1738878100.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532025000022/wk-form4_1738878100.xml","form_type":"4"}},{"id":326548,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Chief Patient & Ext Af Off"}}],"security":"Common Stock","published_at":"2025-02-06T21:41:46.000Z","date":"2025-02-04","kind":"grant","planned":false,"acquired":true,"shares":8210,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents earned performance shares with respect to a performance stock unit award granted on 02/01/2022 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/04/2025 and the shares will vest on 02/26/2025."}],"balance_after":65533,"source":{"system":"sec-edgar","filing":"0000875320-25-000022","document":"wk-form4_1738878100.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532025000022/wk-form4_1738878100.xml","form_type":"4"}},{"id":332968,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Chief Patient & Ext Af Off"}}],"security":"Common Stock","published_at":"2024-06-07T20:07:40.000Z","date":"2024-06-05","kind":"gift","planned":false,"acquired":false,"shares":4600,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held in Trust"},"balance_after":0,"source":{"system":"sec-edgar","filing":"0000875320-24-000172","document":"wk-form4_1717790851.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532024000172/wk-form4_1717790851.xml","form_type":"4"}},{"id":333647,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Chief Patient & Ext Af Off"}}],"security":"Common Stock","published_at":"2024-05-17T20:27:50.000Z","date":"2024-05-15","kind":"sale","planned":true,"acquired":false,"shares":32,"price":430.93,"value":13789.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1, which was entered into on 05/09/2023."}],"balance_after":55325,"source":{"system":"sec-edgar","filing":"0000875320-24-000154","document":"wk-form4_1715977634.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532024000154/wk-form4_1715977634.xml","form_type":"4"}},{"id":339121,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Chief Patient & Ext Af Off"}}],"security":"Common Stock","published_at":"2024-02-27T21:59:03.000Z","date":"2024-02-26","kind":"sale","planned":true,"acquired":false,"shares":3004,"price":425.7,"value":1278802.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1, which was entered into on 05/09/2023."}],"balance_after":55325,"source":{"system":"sec-edgar","filing":"0000875320-24-000107","document":"wk-form4_1709071114.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532024000107/wk-form4_1709071114.xml","form_type":"4"}},{"id":339120,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Chief Patient & Ext Af Off"}}],"security":"Common Stock","published_at":"2024-02-27T21:59:03.000Z","date":"2024-02-23","kind":"tax_withholding","planned":true,"acquired":false,"shares":2469,"price":431.79,"value":1066089.51,"ownership":{"direct":true},"balance_after":58329,"source":{"system":"sec-edgar","filing":"0000875320-24-000107","document":"wk-form4_1709071114.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532024000107/wk-form4_1709071114.xml","form_type":"4"}},{"id":339399,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Chief Patient & Ext Af Off"}}],"security":"Common Stock","published_at":"2024-02-23T21:20:30.000Z","date":"2024-02-21","kind":"sale","planned":true,"acquired":false,"shares":3191,"price":421.77,"value":1345868.07,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1, which was entered into on 05/09/2023."}],"balance_after":60798,"source":{"system":"sec-edgar","filing":"0000875320-24-000091","document":"wk-form4_1708723213.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532024000091/wk-form4_1708723213.xml","form_type":"4"}},{"id":339690,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Chief Patient & Ext Af Off"}}],"security":"Common Stock","published_at":"2024-02-21T21:38:30.000Z","date":"2024-02-20","kind":"sale","planned":true,"acquired":false,"shares":4254,"price":420.79,"value":1790040.66,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1, which was entered into on 05/09/2023."}],"balance_after":63989,"source":{"system":"sec-edgar","filing":"0000875320-24-000078","document":"wk-form4_1708551484.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532024000078/wk-form4_1708551484.xml","form_type":"4"}},{"id":339689,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Chief Patient & Ext Af Off"}}],"security":"Common Stock","published_at":"2024-02-21T21:38:30.000Z","date":"2024-02-20","kind":"tax_withholding","planned":true,"acquired":false,"shares":2623,"price":420.58,"value":1103181.34,"ownership":{"direct":true},"balance_after":68243,"source":{"system":"sec-edgar","filing":"0000875320-24-000078","document":"wk-form4_1708551484.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532024000078/wk-form4_1708551484.xml","form_type":"4"}},{"id":339688,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Chief Patient & Ext Af Off"}}],"security":"Common Stock","published_at":"2024-02-21T21:38:30.000Z","date":"2024-02-16","kind":"tax_withholding","planned":true,"acquired":false,"shares":3498,"price":424.01,"value":1483186.98,"ownership":{"direct":true},"balance_after":70866,"source":{"system":"sec-edgar","filing":"0000875320-24-000078","document":"wk-form4_1708551484.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532024000078/wk-form4_1708551484.xml","form_type":"4"}},{"id":340494,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Chief Patient & Ext Af Off"}}],"security":"Common Stock","published_at":"2024-02-13T22:15:30.000Z","date":"2024-02-12","kind":"sale","planned":true,"acquired":false,"shares":3222,"price":420.24,"value":1354013.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1, which was entered into on 05/09/2023."}],"balance_after":74364,"source":{"system":"sec-edgar","filing":"0000875320-24-000053","document":"wk-form4_1707862481.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532024000053/wk-form4_1707862481.xml","form_type":"4"}},{"id":340493,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Chief Patient & Ext Af Off"}}],"security":"Common Stock","published_at":"2024-02-13T22:15:30.000Z","date":"2024-02-09","kind":"tax_withholding","planned":true,"acquired":false,"shares":2022,"price":422.74,"value":854780.28,"ownership":{"direct":true},"balance_after":77586,"source":{"system":"sec-edgar","filing":"0000875320-24-000053","document":"wk-form4_1707862481.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532024000053/wk-form4_1707862481.xml","form_type":"4"}},{"id":341068,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Chief Patient & Ext Af Off"}}],"security":"Common Stock","published_at":"2024-02-08T21:43:12.000Z","date":"2024-02-07","kind":"grant","planned":false,"acquired":true,"shares":7114,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Restricted stock unit award that vests in installments beginning on 02/17/2025."}],"balance_after":79608,"source":{"system":"sec-edgar","filing":"0000875320-24-000030","document":"wk-form4_1707428580.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532024000030/wk-form4_1707428580.xml","form_type":"4"}},{"id":341067,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Chief Patient & Ext Af Off"}}],"security":"Common Stock","published_at":"2024-02-08T21:43:12.000Z","date":"2024-02-06","kind":"grant","planned":false,"acquired":true,"shares":7866,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents earned performance shares with respect to a performance stock unit award granted on 02/01/2023 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on  02/06/2024 and the shares will vest in installments beginning on 02/10/2024."}],"balance_after":72494,"source":{"system":"sec-edgar","filing":"0000875320-24-000030","document":"wk-form4_1707428580.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532024000030/wk-form4_1707428580.xml","form_type":"4"}},{"id":341066,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Chief Patient & Ext Af Off"}}],"security":"Common Stock","published_at":"2024-02-08T21:43:12.000Z","date":"2024-02-06","kind":"grant","planned":false,"acquired":true,"shares":5814,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents earned performance shares with respect to a performance stock unit award granted on 02/03/2021 that contained performance-vesting requirements. The issuer's management development and compensation\ncommittee certified as to the level of performance-goal attainment on 02/06/2024 and the shares will vest on 02/20/2024."}],"balance_after":64628,"source":{"system":"sec-edgar","filing":"0000875320-24-000030","document":"wk-form4_1707428580.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532024000030/wk-form4_1707428580.xml","form_type":"4"}},{"id":344374,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Chief Patient & Ext Af Off"}}],"security":"Common Stock","published_at":"2023-11-17T21:16:41.000Z","date":"2023-11-15","kind":"sale","planned":true,"acquired":false,"shares":35,"price":369.92,"value":12947.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1, which was entered into on 05/09/2023."}],"balance_after":58814,"source":{"system":"sec-edgar","filing":"0000875320-23-000041","document":"wk-form4_1700255780.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532023000041/wk-form4_1700255780.xml","form_type":"4"}},{"id":346635,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Patient Officer"}}],"security":"Common Stock","published_at":"2023-08-14T20:05:14.000Z","date":"2023-08-10","kind":"sale","planned":true,"acquired":false,"shares":10031,"price":350,"value":3510850.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1, which was entered into on 05/09/2023."}],"balance_after":58814,"source":{"system":"sec-edgar","filing":"0000899243-23-018109","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924323018109/doc4.xml","form_type":"4"}},{"id":1972699,"issuer":{"id":16554,"kind":"organization","name":"Eiger BioPharmaceuticals, Inc.","symbol":"EIGR"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-04T01:50:28.000Z","date":"2023-03-01","kind":"grant","acquired":true,"shares":28000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in equal monthly installments over 12 months measured from March 1, 2023, subject to Reporting Person's continuous service status as of each such date."}],"balance_after":28000,"derivative":{"exercise_price":1.705,"expiration_date":"2033-02-28","underlying":"Common Stock","underlying_shares":28000},"source":{"system":"sec-edgar","filing":"0001140361-23-010164","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1406338/000114036123010164/form4.xml","form_type":"4"}},{"id":352327,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Patient Officer"}}],"security":"Common Stock","published_at":"2023-02-28T22:02:04.000Z","date":"2023-02-24","kind":"tax_withholding","acquired":false,"shares":2468,"price":289.12,"value":713548.16,"ownership":{"direct":true},"balance_after":66518,"source":{"system":"sec-edgar","filing":"0001209191-23-013744","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123013744/doc4.xml","form_type":"4"}},{"id":352890,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Patient Officer"}}],"security":"Common Stock","published_at":"2023-02-22T21:43:10.000Z","date":"2023-02-17","kind":"tax_withholding","acquired":false,"shares":3498,"price":292.85,"value":1024389.3,"ownership":{"direct":true},"balance_after":68986,"source":{"system":"sec-edgar","filing":"0001209191-23-011699","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123011699/doc4.xml","form_type":"4"}},{"id":353527,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Patient Officer"}}],"security":"Common Stock","published_at":"2023-02-14T22:06:18.000Z","date":"2023-02-13","kind":"tax_withholding","acquired":false,"shares":4657,"price":298.26,"value":1388996.82,"ownership":{"direct":true},"balance_after":72484,"source":{"system":"sec-edgar","filing":"0001209191-23-009226","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123009226/doc4.xml","form_type":"4"}},{"id":353526,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Patient Officer"}}],"security":"Common Stock","published_at":"2023-02-14T22:06:18.000Z","date":"2023-02-10","kind":"tax_withholding","acquired":false,"shares":2611,"price":294.33,"value":768495.63,"ownership":{"direct":true},"balance_after":77141,"source":{"system":"sec-edgar","filing":"0001209191-23-009226","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123009226/doc4.xml","form_type":"4"}},{"id":354148,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Patient Officer"}}],"security":"Common Stock","published_at":"2023-02-03T21:56:38.000Z","date":"2023-02-01","kind":"grant","acquired":true,"shares":7866,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Restricted stock unit award that vests in installments beginning on 02/10/2024."}],"balance_after":79752,"source":{"system":"sec-edgar","filing":"0001209191-23-006973","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123006973/doc4.xml","form_type":"4"}},{"id":354147,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Patient Officer"}}],"security":"Common Stock","published_at":"2023-02-03T21:56:38.000Z","date":"2023-02-01","kind":"grant","acquired":true,"shares":8210,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents earned performance shares with respect to a performance stock unit award granted on 02/01/2022 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/01/2023 and the shares will vest in installments beginning on 02/24/2023."}],"balance_after":71886,"source":{"system":"sec-edgar","filing":"0001209191-23-006973","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123006973/doc4.xml","form_type":"4"}},{"id":354146,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Patient Officer"}}],"security":"Common Stock","published_at":"2023-02-03T21:56:38.000Z","date":"2023-02-01","kind":"grant","acquired":true,"shares":10324,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents earned performance shares with respect to a performance stock unit award granted on 02/05/2020 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/01/2023 and the shares will vest on 02/13/2023."}],"balance_after":63676,"source":{"system":"sec-edgar","filing":"0001209191-23-006973","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123006973/doc4.xml","form_type":"4"}},{"id":354145,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Patient Officer"}}],"security":"Common Stock","published_at":"2023-02-03T21:56:38.000Z","date":"2022-05-17","kind":"gift","acquired":false,"shares":1672,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held in Trust"},"balance_after":11052,"source":{"system":"sec-edgar","filing":"0001209191-23-006973","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123006973/doc4.xml","form_type":"4"}},{"id":2337412,"issuer":{"id":16554,"kind":"organization","name":"Eiger BioPharmaceuticals, Inc.","symbol":"EIGR"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-12T02:07:05.000Z","date":"2022-03-11","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in equal monthly installments over 12 months measured from March 11, 2022 subject to Reporting Person's continuous service status as of each such date."}],"balance_after":12000,"derivative":{"exercise_price":5.1,"expiration_date":"2032-03-10","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001140361-22-009264","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1406338/000114036122009264/form4.xml","form_type":"4"}},{"id":2337411,"issuer":{"id":16554,"kind":"organization","name":"Eiger BioPharmaceuticals, Inc.","symbol":"EIGR"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-03-12T02:07:05.000Z","date":"2022-03-11","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying Restricted Stock Units award that will vest on the first anniversary of the grant date of March 11, 2022."}],"balance_after":16000,"source":{"system":"sec-edgar","filing":"0001140361-22-009264","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1406338/000114036122009264/form4.xml","form_type":"4"}},{"id":365009,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Patient Officer"}}],"security":"Common Stock","published_at":"2022-02-28T22:25:57.000Z","date":"2022-02-24","kind":"tax_withholding","acquired":false,"shares":7368,"price":227.86,"value":1678872.48,"ownership":{"direct":true},"balance_after":48210,"source":{"system":"sec-edgar","filing":"0000899243-22-008121","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322008121/doc4.xml","form_type":"4"}},{"id":365561,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Patient Officer"}}],"security":"Common Stock","published_at":"2022-02-22T22:01:16.000Z","date":"2022-02-17","kind":"tax_withholding","acquired":false,"shares":3497,"price":232.51,"value":813087.47,"ownership":{"direct":true},"balance_after":55578,"source":{"system":"sec-edgar","filing":"0000899243-22-007214","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322007214/doc4.xml","form_type":"4"}},{"id":366085,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Patient Officer"}}],"security":"Common Stock","published_at":"2022-02-14T21:20:00.000Z","date":"2022-02-10","kind":"tax_withholding","acquired":false,"shares":2491,"price":237.74,"value":592210.34,"ownership":{"direct":true},"balance_after":59075,"source":{"system":"sec-edgar","filing":"0001209191-22-009242","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919122009242/doc4.xml","form_type":"4"}},{"id":366662,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Patient Officer"}}],"security":"Common Stock","published_at":"2022-02-03T21:24:11.000Z","date":"2022-02-01","kind":"grant","acquired":true,"shares":8210,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Restricted stock unit award that vests in installments beginning on 02/24/2023."}],"balance_after":61566,"source":{"system":"sec-edgar","filing":"0001209191-22-006788","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919122006788/doc4.xml","form_type":"4"}},{"id":366661,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Patient Officer"}}],"security":"Common Stock","published_at":"2022-02-03T21:24:11.000Z","date":"2022-02-01","kind":"grant","acquired":true,"shares":11628,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents earned performance shares with respect to a performance stock unit award granted on 02/03/2021 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/01/2022 and the shares will vest in installments beginning on 02/17/2022."}],"balance_after":53356,"source":{"system":"sec-edgar","filing":"0001209191-22-006788","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919122006788/doc4.xml","form_type":"4"}},{"id":366660,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Patient Officer"}}],"security":"Common Stock","published_at":"2022-02-03T21:24:11.000Z","date":"2022-02-01","kind":"grant","acquired":true,"shares":9800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents earned performance shares with respect to a performance stock unit award granted on 02/06/2019 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/01/2022 and the shares will vest on 02/24/2022."}],"balance_after":41728,"source":{"system":"sec-edgar","filing":"0001209191-22-006788","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919122006788/doc4.xml","form_type":"4"}},{"id":369585,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Patient Officer"}}],"security":"Common Stock","published_at":"2021-11-16T21:07:33.000Z","date":"2021-11-15","kind":"sale","acquired":false,"shares":30,"price":187.48,"value":5624.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $187.48 (range $187.24 to $187.85)."}],"balance_after":31928,"source":{"system":"sec-edgar","filing":"0001209191-21-064740","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121064740/doc4.xml","form_type":"4"}},{"id":369584,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Patient Officer"}}],"security":"Common Stock","published_at":"2021-11-16T21:07:33.000Z","date":"2021-11-15","kind":"sale","acquired":false,"shares":21,"price":186.78,"value":3922.38,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Open market sales reported on this line occurred at a weighted average price of $186.78 (range $186.22 to $187.19)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":31958,"source":{"system":"sec-edgar","filing":"0001209191-21-064740","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121064740/doc4.xml","form_type":"4"}},{"id":375223,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Patient Officer"}}],"security":"Common Stock","published_at":"2021-05-19T20:08:20.000Z","date":"2021-05-17","kind":"sale","acquired":false,"shares":5,"price":217.27,"value":1086.35,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Open market sales reported on this line occurred at a weighted average price of $217.27 (range $217.05 to $217.46)."}],"balance_after":40133,"source":{"system":"sec-edgar","filing":"0001209191-21-033989","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121033989/doc4.xml","form_type":"4"}},{"id":375222,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Patient Officer"}}],"security":"Common Stock","published_at":"2021-05-19T20:08:20.000Z","date":"2021-05-17","kind":"sale","acquired":false,"shares":32,"price":216.4,"value":6924.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $216.40 (range $215.95 to $216.91)."}],"balance_after":40138,"source":{"system":"sec-edgar","filing":"0001209191-21-033989","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121033989/doc4.xml","form_type":"4"}},{"id":375221,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Patient Officer"}}],"security":"Common Stock","published_at":"2021-05-19T20:08:20.000Z","date":"2021-05-17","kind":"sale","acquired":false,"shares":8,"price":215.59,"value":1724.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Open market sales reported on this line occurred at a weighted average price of $215.59 (range $214.94 to $215.93)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":40170,"source":{"system":"sec-edgar","filing":"0001209191-21-033989","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121033989/doc4.xml","form_type":"4"}},{"id":376287,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Patient Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-29T20:03:30.000Z","date":"2021-04-27","kind":"exercise","acquired":false,"shares":3884,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Fully vested."}],"balance_after":0,"derivative":{"exercise_price":86.52,"expiration_date":"2027-02-02","underlying":"Common Stock","underlying_shares":3884},"source":{"system":"sec-edgar","filing":"0001209191-21-028984","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121028984/doc4.xml","form_type":"4"}},{"id":376286,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Patient Officer"}}],"security":"Common Stock","published_at":"2021-04-29T20:03:30.000Z","date":"2021-04-27","kind":"sale","acquired":false,"shares":200,"price":217.69,"value":43538.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Open market sales reported on this line occurred at a weighted average price of $217.69 (range $217.60 to $217.78)."}],"balance_after":40133,"source":{"system":"sec-edgar","filing":"0001209191-21-028984","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121028984/doc4.xml","form_type":"4"}},{"id":376285,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Patient Officer"}}],"security":"Common Stock","published_at":"2021-04-29T20:03:30.000Z","date":"2021-04-27","kind":"sale","acquired":false,"shares":1338,"price":216.67,"value":289904.46,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $216.67 (range $216.19 to $217.18)."}],"balance_after":40333,"source":{"system":"sec-edgar","filing":"0001209191-21-028984","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121028984/doc4.xml","form_type":"4"}},{"id":376284,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Patient Officer"}}],"security":"Common Stock","published_at":"2021-04-29T20:03:30.000Z","date":"2021-04-27","kind":"sale","acquired":false,"shares":2346,"price":215.58,"value":505750.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Open market sales reported on this line occurred at a weighted average price of $215.58 (range $215.09 to $216.07)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":41671,"source":{"system":"sec-edgar","filing":"0001209191-21-028984","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121028984/doc4.xml","form_type":"4"}},{"id":376283,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Patient Officer"}}],"security":"Common Stock","published_at":"2021-04-29T20:03:30.000Z","date":"2021-04-27","kind":"exercise","acquired":true,"shares":3884,"price":86.52,"value":336043.68,"ownership":{"direct":true},"balance_after":44017,"source":{"system":"sec-edgar","filing":"0001209191-21-028984","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121028984/doc4.xml","form_type":"4"}},{"id":2789060,"issuer":{"id":16554,"kind":"organization","name":"Eiger BioPharmaceuticals, Inc.","symbol":"EIGR"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-15T23:39:41.000Z","date":"2021-03-12","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in equal monthly installments over 12 months measured from March 12, 2021 subject to Reporting Person's continuous service status as of each such date."}],"balance_after":10000,"derivative":{"exercise_price":9.99,"expiration_date":"2031-03-11","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-21-020593","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1406338/000120919121020593/doc4.xml","form_type":"4"}},{"id":2789059,"issuer":{"id":16554,"kind":"organization","name":"Eiger BioPharmaceuticals, Inc.","symbol":"EIGR"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-15T23:39:41.000Z","date":"2021-03-12","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying Restricted Stock Units award that will vest on the first anniversary of the grant date of March 12, 2021."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001209191-21-020593","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1406338/000120919121020593/doc4.xml","form_type":"4"}},{"id":379378,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Patient Officer"}}],"security":"Common Stock","published_at":"2021-02-26T21:20:32.000Z","date":"2021-02-25","kind":"sale","acquired":false,"shares":200,"price":216.62,"value":43324.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1."}],"balance_after":40133,"source":{"system":"sec-edgar","filing":"0001209191-21-014743","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121014743/doc4.xml","form_type":"4"}},{"id":379377,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Patient Officer"}}],"security":"Common Stock","published_at":"2021-02-26T21:20:32.000Z","date":"2021-02-25","kind":"sale","acquired":false,"shares":336,"price":215.56,"value":72428.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Open market sales reported on this line occurred at a weighted average price of $215.56 (range $215.12 to $215.85)."}],"balance_after":40333,"source":{"system":"sec-edgar","filing":"0001209191-21-014743","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121014743/doc4.xml","form_type":"4"}},{"id":379376,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Patient Officer"}}],"security":"Common Stock","published_at":"2021-02-26T21:20:32.000Z","date":"2021-02-25","kind":"sale","acquired":false,"shares":668,"price":214.19,"value":143078.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Open market sales reported on this line occurred at a weighted average price of $214.19 (range $213.94 to $214.78)."}],"balance_after":40669,"source":{"system":"sec-edgar","filing":"0001209191-21-014743","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121014743/doc4.xml","form_type":"4"}},{"id":379375,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Patient Officer"}}],"security":"Common Stock","published_at":"2021-02-26T21:20:32.000Z","date":"2021-02-25","kind":"sale","acquired":false,"shares":1460,"price":213.3,"value":311418.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $213.30 (range $212.93 to $213.88)."}],"balance_after":41337,"source":{"system":"sec-edgar","filing":"0001209191-21-014743","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121014743/doc4.xml","form_type":"4"}},{"id":379374,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Patient Officer"}}],"security":"Common Stock","published_at":"2021-02-26T21:20:32.000Z","date":"2021-02-25","kind":"sale","acquired":false,"shares":922,"price":211.56,"value":195058.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Open market sales reported on this line occurred at a weighted average price of $211.56 (range $211.06 to $211.87)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":42797,"source":{"system":"sec-edgar","filing":"0001209191-21-014743","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121014743/doc4.xml","form_type":"4"}},{"id":379373,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Patient Officer"}}],"security":"Common Stock","published_at":"2021-02-26T21:20:32.000Z","date":"2021-02-24","kind":"tax_withholding","acquired":false,"shares":2946,"price":217.57,"value":640961.22,"ownership":{"direct":true},"balance_after":43719,"source":{"system":"sec-edgar","filing":"0001209191-21-014743","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121014743/doc4.xml","form_type":"4"}},{"id":379872,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Patient Officer"}}],"security":"Common Stock","published_at":"2021-02-19T21:20:16.000Z","date":"2021-02-18","kind":"sale","acquired":false,"shares":800,"price":213.02,"value":170416.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Sachdev's company-approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Open market sales reported on this line occurred at a weighted average price of $213.02 (range $212.74 to $213.33)."}],"balance_after":46665,"source":{"system":"sec-edgar","filing":"0001209191-21-012352","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121012352/doc4.xml","form_type":"4"}},{"id":379871,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Patient Officer"}}],"security":"Common Stock","published_at":"2021-02-19T21:20:16.000Z","date":"2021-02-18","kind":"sale","acquired":false,"shares":5800,"price":212.15,"value":1230470.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Sachdev's company-approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Open market sales reported on this line occurred at a weighted average price of $212.15 (range $211.74 to $212.70)."}],"balance_after":47465,"source":{"system":"sec-edgar","filing":"0001209191-21-012352","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121012352/doc4.xml","form_type":"4"}},{"id":379870,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Patient Officer"}}],"security":"Common Stock","published_at":"2021-02-19T21:20:16.000Z","date":"2021-02-18","kind":"sale","acquired":false,"shares":1500,"price":211.36,"value":317040.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Sachdev's company-approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $211.36 (range $210.74 to $211.64)."}],"balance_after":53265,"source":{"system":"sec-edgar","filing":"0001209191-21-012352","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121012352/doc4.xml","form_type":"4"}},{"id":379869,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Patient Officer"}}],"security":"Common Stock","published_at":"2021-02-19T21:20:16.000Z","date":"2021-02-18","kind":"sale","acquired":false,"shares":1164,"price":210,"value":244440.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Sachdev's company-approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Open market sales reported on this line occurred at a weighted average price of $210.00 (range $209.61 to $210.34)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":54765,"source":{"system":"sec-edgar","filing":"0001209191-21-012352","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121012352/doc4.xml","form_type":"4"}},{"id":379868,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Patient Officer"}}],"security":"Common Stock","published_at":"2021-02-19T21:20:16.000Z","date":"2021-02-17","kind":"tax_withholding","acquired":false,"shares":7613,"price":211.75,"value":1612052.75,"ownership":{"direct":true},"balance_after":55929,"source":{"system":"sec-edgar","filing":"0001209191-21-012352","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121012352/doc4.xml","form_type":"4"}},{"id":380320,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Patient Officer"}}],"security":"Common Stock","published_at":"2021-02-16T21:20:29.000Z","date":"2021-02-11","kind":"sale","acquired":false,"shares":100,"price":211.98,"value":21198.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1."}],"balance_after":63542,"source":{"system":"sec-edgar","filing":"0001209191-21-010723","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121010723/doc4.xml","form_type":"4"}},{"id":380319,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Patient Officer"}}],"security":"Common Stock","published_at":"2021-02-16T21:20:29.000Z","date":"2021-02-11","kind":"sale","acquired":false,"shares":500,"price":211.22,"value":105610.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $211.22 (range $210.92 to $211.87)."}],"balance_after":63642,"source":{"system":"sec-edgar","filing":"0001209191-21-010723","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121010723/doc4.xml","form_type":"4"}},{"id":380318,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Patient Officer"}}],"security":"Common Stock","published_at":"2021-02-16T21:20:29.000Z","date":"2021-02-11","kind":"sale","acquired":false,"shares":3860,"price":210.43,"value":812259.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Open market sales reported on this line occurred at a weighted average price of $210.43 (range $209.89 to $210.87)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":64142,"source":{"system":"sec-edgar","filing":"0001209191-21-010723","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121010723/doc4.xml","form_type":"4"}},{"id":380487,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Patient Officer"}}],"security":"Common Stock","published_at":"2021-02-12T21:13:17.000Z","date":"2021-02-10","kind":"tax_withholding","acquired":false,"shares":2421,"price":214.16,"value":518481.36,"ownership":{"direct":true},"balance_after":68002,"source":{"system":"sec-edgar","filing":"0001209191-21-010115","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121010115/doc4.xml","form_type":"4"}},{"id":380788,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Patient Officer"}}],"security":"Common Stock","published_at":"2021-02-05T21:53:52.000Z","date":"2021-02-03","kind":"grant","acquired":true,"shares":11627,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Restricted stock unit award that vests in installments beginning on 02/17/2022."}],"balance_after":70423,"source":{"system":"sec-edgar","filing":"0001209191-21-008136","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121008136/doc4.xml","form_type":"4"}},{"id":380787,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Patient Officer"}}],"security":"Common Stock","published_at":"2021-02-05T21:53:52.000Z","date":"2021-02-03","kind":"grant","acquired":true,"shares":10324,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents earned performance shares with respect to a performance stock unit award granted on 02/05/2020 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/03/2021 and the shares will vest in installments beginning on 02/10/2021."}],"balance_after":58796,"source":{"system":"sec-edgar","filing":"0001209191-21-008136","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121008136/doc4.xml","form_type":"4"}},{"id":380786,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Patient Officer"}}],"security":"Common Stock","published_at":"2021-02-05T21:53:52.000Z","date":"2021-02-03","kind":"grant","acquired":true,"shares":10126,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents earned performance shares with respect to a performance stock unit award granted on 02/06/2018 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/03/2021 and the shares will vest on 02/17/2021."}],"balance_after":48472,"source":{"system":"sec-edgar","filing":"0001209191-21-008136","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121008136/doc4.xml","form_type":"4"}},{"id":380785,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Patient Officer"}}],"security":"Common Stock","published_at":"2021-02-05T21:53:52.000Z","date":"2020-12-08","kind":"gift","acquired":false,"shares":3391,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held in trust"},"balance_after":7368,"source":{"system":"sec-edgar","filing":"0001209191-21-008136","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121008136/doc4.xml","form_type":"4"}},{"id":383792,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Patient Officer"}}],"security":"Common Stock","published_at":"2020-11-18T21:16:05.000Z","date":"2020-11-16","kind":"sale","acquired":false,"shares":8,"price":224.44,"value":1795.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Open market sales reported on this line occurred at a weighted average price of $224.44 (range $224.20 to $224.70)."}],"balance_after":35103,"source":{"system":"sec-edgar","filing":"0001209191-20-059069","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120059069/doc4.xml","form_type":"4"}},{"id":383791,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Patient Officer"}}],"security":"Common Stock","published_at":"2020-11-18T21:16:05.000Z","date":"2020-11-16","kind":"sale","acquired":false,"shares":22,"price":223.76,"value":4922.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $223.76 (range $223.17 to $224.14)."}],"balance_after":35111,"source":{"system":"sec-edgar","filing":"0001209191-20-059069","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120059069/doc4.xml","form_type":"4"}},{"id":383790,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Patient Officer"}}],"security":"Common Stock","published_at":"2020-11-18T21:16:05.000Z","date":"2020-11-16","kind":"sale","acquired":false,"shares":12,"price":222.5,"value":2670.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Open market sales reported on this line occurred at a weighted average price of $222.50 (range $222.03 to $222.89)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":35133,"source":{"system":"sec-edgar","filing":"0001209191-20-059069","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120059069/doc4.xml","form_type":"4"}},{"id":387544,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Patient Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-08-05T20:51:28.000Z","date":"2020-08-03","kind":"exercise","acquired":false,"shares":1941,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option vests in 16 quarterly installments from 02/03/2017."}],"balance_after":3884,"derivative":{"exercise_price":86.52,"expiration_date":"2027-02-02","underlying":"Common Stock","underlying_shares":1941},"source":{"system":"sec-edgar","filing":"0001209191-20-045145","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120045145/doc4.xml","form_type":"4"}},{"id":387543,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Patient Officer"}}],"security":"Common Stock","published_at":"2020-08-05T20:51:28.000Z","date":"2020-08-03","kind":"sale","acquired":false,"shares":751,"price":279.18,"value":209664.18,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Open market sales reported on this line occurred at a weighted average price of $279.18 (range $278.92 to $279.61)."}],"balance_after":35103,"source":{"system":"sec-edgar","filing":"0001209191-20-045145","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120045145/doc4.xml","form_type":"4"}},{"id":387542,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Patient Officer"}}],"security":"Common Stock","published_at":"2020-08-05T20:51:28.000Z","date":"2020-08-03","kind":"sale","acquired":false,"shares":690,"price":278.25,"value":191992.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $278.25 (range $277.73 to $278.48)."}],"balance_after":35854,"source":{"system":"sec-edgar","filing":"0001209191-20-045145","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120045145/doc4.xml","form_type":"4"}},{"id":387541,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Patient Officer"}}],"security":"Common Stock","published_at":"2020-08-05T20:51:28.000Z","date":"2020-08-03","kind":"sale","acquired":false,"shares":500,"price":276.96,"value":138480.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Open market sales reported on this line occurred at a weighted average price of $276.96 (range $276.62 to $277.25)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":36544,"source":{"system":"sec-edgar","filing":"0001209191-20-045145","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120045145/doc4.xml","form_type":"4"}},{"id":387540,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Patient Officer"}}],"security":"Common Stock","published_at":"2020-08-05T20:51:28.000Z","date":"2020-08-03","kind":"exercise","acquired":true,"shares":1941,"price":86.52,"value":167935.32,"ownership":{"direct":true},"balance_after":37044,"source":{"system":"sec-edgar","filing":"0001209191-20-045145","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120045145/doc4.xml","form_type":"4"}},{"id":390340,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14405,"kind":"person","name":"Sachdev Amit","position":1,"cik":"0001406338","reported_name":"Sachdev Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Patient Officer"}}],"security":"Common Stock","published_at":"2020-05-19T20:29:44.000Z","date":"2020-05-15","kind":"sale","acquired":false,"shares":6,"price":288.36,"value":1730.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"Open market sales reported on this line occurred at a weighted average price of $288.36 (range $288.23 to $288.47)."}],"balance_after":35103,"source":{"system":"sec-edgar","filing":"0001209191-20-030482","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120030482/doc4.xml","form_type":"4"}}],"next_cursor":"2020-05-19T20:29:44.000000Z,390340"}